2 weeks Ago By Defense World Staff
American Century Companies Inc. decreased its position in Doximity, Inc. (NASDAQ:DOCS – Free Report) by 47.
3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 111,927 shares of the company’s stock after selling 100,402 shares during the quarter. American Century Companies Inc.
owned approximately 0.06% of Doximity worth $5,976,000 at the end of the most recent quarter. Other institutional investors and hedge funds have also added to or reduced their stakes in the company.
Global Retirement Partners LLC grew its stake in shares of Doximity by 468.1% in the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock worth $29,000 after buying an additional 440 shares during the last quarter.
UMB Bank n.a. boosted its holdings in Doximity by 69.
1% in the fourth quarter. UMB Bank n.a.
now owns 575 shares of the company’s stock worth $31,000 after acquiring an additional 235 shares in the last quarter. Larson Financial Group LLC grew its stake in shares of Doximity by 49.4% in the fourth quarter.
Larson Financial Group LLC now owns 756 shares of the company’s stock worth $40,000 after acquiring an additional 250 shares during the last quarter. Morse Asset Management Inc bought a new position in shares of Doximity during the third quarter valued at $46,000. Finally, IFP Advisors Inc raised its position in shares of Doximity by 344.
1% in the 4th quarter. IFP Advisors Inc now owns 1,328 shares of the company’s stock worth $71,000 after purchasing an additional 1,029 shares during the last quarter. Hedge funds and other institutional investors own 87.
19% of the company’s stock. Doximity Price PerformanceShares of DOCS stock opened at $51.23 on Friday.
The company has a market cap of $9.56 billion, a price-to-earnings ratio of 51.23, a PEG ratio of 4.
10 and a beta of 1.34. Doximity, Inc.
has a 1 year low of $22.96 and a 1 year high of $85.21.
The firm has a fifty day moving average price of $65.50 and a 200-day moving average price of $54.92.
Insider Activity at DoximityIn other news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.
62, for a total value of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares of the company’s stock, valued at $366,463.
20. This represents a 75.87 % decrease in their ownership of the stock.
The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 37.40% of the stock is owned by company insiders.
Wall Street Analysts Forecast GrowthDOCS has been the subject of a number of analyst reports. Needham & Company LLC raised their price objective on shares of Doximity from $65.00 to $82.
00 and gave the company a “buy” rating in a research note on Friday, February 7th. Raymond James reissued an “outperform” rating and set a $83.00 price target (up previously from $65.
00) on shares of Doximity in a research report on Friday, February 7th. Stephens assumed coverage on Doximity in a research report on Friday, December 20th. They issued an “equal weight” rating and a $55.
00 price objective on the stock. KeyCorp reduced their target price on Doximity from $70.00 to $65.
00 and set an “overweight” rating for the company in a report on Wednesday, January 8th. Finally, Mizuho upped their price target on Doximity from $55.00 to $65.
00 and gave the company a “neutral” rating in a report on Monday, February 10th. Eleven investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $64.
22.View Our Latest Stock Analysis on DOCSDoximity Company Profile (Free Report)Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
See AlsoFive stocks we like better than DoximityBusiness Services Stocks InvestingArcher Aviation’s Africa Deal Could Boost ACHR StockThe Significance of a Trillion-Dollar Market Cap Goes Beyond a NumberAre Short Sellers Wrong About These 3 Semiconductor Stocks?How to trade penny stocks: A step-by-step guideBoeing Gets $50B in March Orders—Is BA Stock a Buy Now?Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Free Report).
.
